Condition: Idiopathic Hypersomnia · Narcolepsy Without Cataplexy · Sponsor: Balance Therapeutics
This is a randomized, placebo-controlled, double-blind, multiple cohort, fixed-dose multiple crossover, dose-finding study of oral BTD-001 in adult patients with IH or Narcolepsy without cataplexy (Type 2).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Sleep Disorders Center of Alabama | Birmingham, Alabama, United States | — |
| Stanford Medicine Sleep Center | Palo Alto, California, United States | — |
| Pacific Research Network | San Diego, California, United States | — |
| Empire Clinical Research | Upland, California, United States | — |
| REM Sleep Medicine, Colorado Sleep Institute | Boulder, Colorado, United States | — |
| PAB Clinical Research | Brandon, Florida, United States | — |
| Clinical Research Group of St. Petersburg | St. Petersburg, Florida, United States | — |
| Emory University School of Medicine Emory Sleep Center | Atlanta, Georgia, United States | — |
| NeuroTrials Research Inc | Atlanta, Georgia, United States | — |
| SleepMed of Central | Macon, Georgia, United States | — |
| Kentucky Research Group, | Louisville, Kentucky, United States | — |
| The Center for Sleep and Wake Disorders | Chevy Chase, Maryland, United States | — |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02512588